Trials / Recruiting
RecruitingNCT07051980
Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is a technique for evaluating the bile duct, pancreatic duct, and ampulla. Hypoxia is the most common cardiopulmonary complication during ERCP, with a reported rate of 16.2 to 39.2%. The key to preventing hypoxia is to ensure the sufficient oxygenation and ventilation of patients during these procedures. The commonly used approaches to treat hypoxia with a non-instrumented airway are increasing the oxygen flow and lifting the jaw, applying with both hands, displacing the jaw upwards and anteriorly, which allowed the upper airway to remain open. We hypothesized that the supraglottic oxygen delivery via an endotracheal tube can reduce the incidence of hypoxia in patients under deep sedation during ERCP.
Conditions
- Choledocholithiasis With Cholecystitis With Obstruction
- Obstructive Jaundice
- Pancreatitis
- Cholelithiasis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Supraglottic Oxygen Delivery via an Endotracheal Tube | patients use the Supraglottic Oxygen Delivery via an Endotracheal Tube |
Timeline
- Start date
- 2025-06-12
- Primary completion
- 2026-12-02
- Completion
- 2026-12-31
- First posted
- 2025-07-04
- Last updated
- 2025-07-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07051980. Inclusion in this directory is not an endorsement.